These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 3031895)
1. Feline leukemia virus envelope protein expression encoded by a recombinant vaccinia virus: apparent lack of immunogenicity in vaccinated animals. Gilbert JH; Pedersen NC; Nunberg JH Virus Res; 1987 Feb; 7(1):49-67. PubMed ID: 3031895 [TBL] [Abstract][Full Text] [Related]
2. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene. Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683 [TBL] [Abstract][Full Text] [Related]
3. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant. Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689 [TBL] [Abstract][Full Text] [Related]
4. Protection against feline leukemia virus infection by use of an inactivated virus vaccine. Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090 [TBL] [Abstract][Full Text] [Related]
5. Development of a genetically engineered vaccine against feline leukemia virus infection. Kensil CR; Barrett C; Kushner N; Beltz G; Storey J; Patel U; Recchia J; Aubert A; Marciani D J Am Vet Med Assoc; 1991 Nov; 199(10):1423-7. PubMed ID: 1666096 [TBL] [Abstract][Full Text] [Related]
6. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom. Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351 [TBL] [Abstract][Full Text] [Related]
7. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine. Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101 [TBL] [Abstract][Full Text] [Related]
8. Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective. Pedersen NC; Johnson L; Birch D; Theilen GH Vet Immunol Immunopathol; 1986 Feb; 11(2):123-48. PubMed ID: 3008409 [TBL] [Abstract][Full Text] [Related]
9. Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E. Langhammer S; Hübner J; Kurth R; Denner J Immunology; 2006 Feb; 117(2):229-37. PubMed ID: 16423059 [TBL] [Abstract][Full Text] [Related]
10. Use of a subunit feline leukemia virus vaccine in exotic cats. Citino SB J Am Vet Med Assoc; 1988 Apr; 192(7):957-9. PubMed ID: 2835347 [TBL] [Abstract][Full Text] [Related]
11. Vaccination against feline leukaemia using a new feline herpesvirus type 1 vector. Willemse MJ; van Schooneveld SH; Chalmers WS; Sondermeijer PJ Vaccine; 1996 Nov; 14(16):1511-6. PubMed ID: 9014292 [TBL] [Abstract][Full Text] [Related]
12. Comparative Efficacy of Feline Leukemia Virus (FeLV) Inactivated Whole-Virus Vaccine and Canarypox Virus-Vectored Vaccine during Virulent FeLV Challenge and Immunosuppression. Patel M; Carritt K; Lane J; Jayappa H; Stahl M; Bourgeois M Clin Vaccine Immunol; 2015 Jul; 22(7):798-805. PubMed ID: 25972402 [TBL] [Abstract][Full Text] [Related]
13. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. Tartaglia J; Jarrett O; Neil JC; Desmettre P; Paoletti E J Virol; 1993 Apr; 67(4):2370-5. PubMed ID: 8383248 [TBL] [Abstract][Full Text] [Related]
14. No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus. Helfer-Hungerbuehler AK; Spiri AM; Riond B; Grest P; Boretti FS; Hofmann-Lehmann R Vaccine; 2015 Mar; 33(13):1578-85. PubMed ID: 25698488 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine. Pedersen NC J Vet Intern Med; 1993; 7(1):34-9. PubMed ID: 8384261 [TBL] [Abstract][Full Text] [Related]
16. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection. Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899 [TBL] [Abstract][Full Text] [Related]
17. Control of feline leukaemia virus. Weijer K; Uytdehaag FG; Osterhaus AD Vet Immunol Immunopathol; 1989 May; 21(1):69-83. PubMed ID: 2549695 [TBL] [Abstract][Full Text] [Related]
18. Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. Riedel N; Hoover EA; Gasper PW; Nicolson MO; Mullins JI J Virol; 1986 Oct; 60(1):242-50. PubMed ID: 3018287 [TBL] [Abstract][Full Text] [Related]
19. Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax Westman M; Norris J; Malik R; Hofmann-Lehmann R; Parr YA; Armstrong E; McDonald M; Hall E; Sheehy P; Hosie MJ Viruses; 2021 Feb; 13(2):. PubMed ID: 33546485 [TBL] [Abstract][Full Text] [Related]
20. Comparison of serological responses in cats vaccinated with two different FeLV vaccine preparations. Osterhaus A; Weijer K; UytdeHaag F; Knell P; Jarrett O; Morein B Vet Rec; 1987 Sep; 121(11):260. PubMed ID: 2825396 [No Abstract] [Full Text] [Related] [Next] [New Search]